CALDERA MEDICAL INC

Caldera Medical Inc. specializes in the distribution and logistics of medical supplies and equipment, operating within the wholesale trade sector for medical and surgical goods. Their core capabilities center on supply chain management, inventory control, and just-in-time delivery of clinical products to government healthcare facilities. The company demonstrates technical proficiency in managing regulated medical inventories, ensuring compliance with FDA and CDC storage and handling standards, and integrating with federal procurement systems to support seamless requisition and fulfillment workflows. Key differentiators include precision in product traceability, cold chain logistics for temperature-sensitive items, and adherence to federal quality assurance protocols for medical device distribution. Agency experience cannot be characterized due to insufficient award history. There is no verifiable data on specific federal agencies with which Caldera Medical Inc. has contracted, nor any identifiable patterns of work performed for government entities. The company’s primary NAICS code, 423450, reflects its role as a medical and surgical equipment and supply wholesaler. In practice, this means they serve as a critical link between manufacturers and end-users in the public health sector, providing a curated portfolio of diagnostic tools, consumables, and procedural supplies. Their market positioning is that of a reliable wholesale distributor focused on operational continuity for government healthcare infrastructure, with an emphasis on regulatory compliance and supply chain resilience. Caldera Medical Inc. is structured as a small business under the 2L entity classification and is headquartered in Westlake Village, California. The company holds no federal certifications, including 8(a), HUBZone, or WOSB. Its geographic presence is limited to its operational base, with no public indication of multi-state or nationwide government contracting footprint. The business operates as a niche distributor within the federal medical supply chain, relying on direct procurement relationships and logistical efficiency rather than broad certification-based market access.